These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21853731)

  • 1. [TBE in an elderly vaccinated couple. Don't forget booster doses to the elderly!].
    Askling HH; Rydgård C; Ostlund MR; Vene S
    Lakartidningen; 2011 Jul 20-Aug 9; 108(29-31):1441-2. PubMed ID: 21853731
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
    Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
    Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
    Zent O; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Broeker M; Banzhoff A; Jilg W
    Vaccine; 2004 Dec; 23(3):312-5. PubMed ID: 15530673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of delayed TBE-vaccine booster.
    Askling HH; Vene S; Rombo L; Lindquist L
    Vaccine; 2012 Jan; 30(3):499-502. PubMed ID: 22122857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection.
    Paulke-Korinek M; Rendi-Wagner P; Kundi M; Laaber B; Wiedermann U; Kollaritsch H
    Vaccine; 2009 Nov; 27(50):7027-30. PubMed ID: 19786143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
    Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
    Plentz A; Jilg W; Schwarz TF; Kuhr HB; Zent O
    Vaccine; 2009 Feb; 27(6):853-6. PubMed ID: 19071180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years.
    Weinberger B; Keller M; Fischer KH; Stiasny K; Neuner C; Heinz FX; Grubeck-Loebenstein B
    Vaccine; 2010 Apr; 28(20):3511-5. PubMed ID: 20332047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunisation against tick-borne encephalitis by widely used vaccines: short-term history and current recommendations.
    Beran J
    Clin Microbiol Infect; 2005 May; 11(5):424-6. PubMed ID: 15819877
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of antibodies after vaccination against tick-borne encephalitis.
    Rendi-Wagner P; Zent O; Jilg W; Plentz A; Beran J; Kollaritsch H
    Int J Med Microbiol; 2006 May; 296 Suppl 40():202-7. PubMed ID: 16524776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tick-borne encephalitis after vaccination: vaccine failure or misdiagnosis.
    Grgič-Vitek M; Avšič-Županc T; Klavs I
    Vaccine; 2010 Oct; 28(46):7396-400. PubMed ID: 20854899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Wiedermann U; Laaber B; Kollaritsch H
    Vaccine; 2007 Jun; 25(27):5097-101. PubMed ID: 17555850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active immunization against tick-borne encephalitis in the elderly].
    Biró J; Regius O
    Z Gerontol; 1985; 18(6):337-9. PubMed ID: 3879415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation.
    Rendi-Wagner P; Kundi M; Zent O; Banzhoff A; Jaehnig P; Stemberger R; Dvorak G; Grumbeck E; Laaber B; Kollaritsch H
    Vaccine; 2004 Dec; 23(4):427-34. PubMed ID: 15530690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.